S-1
XBRL
REGISTRATION STATEMENT
- Company
- Actinium Pharmaceuticals, Inc.
- Filed
- January 31, 2014
- Accession Number
- 0001213900-14-000604
An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →